A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a...

Clinical Cancer Research 2010 / 03 Vol. 16; Iss. 6

A Phase I Pharmacologic Study of Necitumumab (IMC-11F8), a Fully Human IgG1 Monoclonal Antibody Directed Against EGFR in Patients with Advanced Solid Malignancies

Kuenen, B., Witteveen, P. O., Ruijter, R., Giaccone, G., Dontabhaktuni, A., Fox, F., Katz, T., Youssoufian, H., Zhu, J., Rowinsky, E. K., Voest, E. E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-09-2425
Date:
March, 2010
File:
PDF, 288 KB
english, 2010
Conversion to is in progress
Conversion to is failed